MUMBAI (Reuters) - India's fifth-largest drugmaker, Cipla Ltd , reported third-quarter profit below analysts' expectations.
Cipla, which gets a majority of its sales from India, posted a net profit of 3.43 billion rupees ($50.58 million) for the quarter ended Dec. 31, slightly above the 3.28 billion reported a year earlier. Analysts, on average, expected a profit of 4.28 billion rupees.
($1 = 67.8200 Indian rupees)
(Reporting by Zeba Siddiqui in Mumbai; Editing by Anupama Dwivedi)